Palmerini, Emanuela
Trent, Jonathan C.
Hornicek Jr, Francis John
Funding for this research was provided by:
Daiichi Sankyo, Inc.
Article History
Accepted: 15 April 2025
First Online: 20 May 2025
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: E.P. has served on advisory boards for Daiichi Sankyo, Deciphera, Eusa Pharma, SynOx Therapeutics, Ipsen, and Servier, outside the submitted work. J.C.T. has served as a consultant for Bayer, Deciphera, Adcendo, Daiichi Sankyo, and Ipsen. F.J.H. has nothing to disclose.